Monthly Archives: January 2022

POLARISqb and PhoreMost announce a Multi-target Collaboration to investigate Next-generation Cancer Therapies
Polaris Quantum Biotech (POLARISqb), and PhoreMost Limited, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, today announced a collaboration to study oncology targets currently considered undruggable.    Under the terms of the agreement, the POLARISqb Tachyon™ quantum computing platform will be used to scan billions of molecules from a large chemical…
Read More